Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Esmo consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
Annals of Oncology, Volume 23, No. 10, Year 2012
Notification
URL copied to clipboard!
Description
Colorectal cancer (CRC) is the most common tumour type in both sexes combined in Western countries. Although screening programmes including the implementation of faecal occult blood test and colonoscopy might be able to reduce mortality by removing precursor lesions and by making diagnosis at an earlier stage, the burden of disease and mortality is still high. Improvement of diagnostic and treatment options increased staging accuracy, functional outcome for early stages as well as survival. Although high quality surgery is still the mainstay of curative treatment, the management of CRC must be a multi-modal approach performed by an experienced multi-disciplinary expert team. Optimal choice of the individual treatment modality according to disease localization and extent, tumour biology and patient factors is able to maintain quality of life, enables long-term survival and even cure in selected patients by a combination of chemotherapy and surgery. Treatment decisions must be based on the available evidence, which has been the basis for this consensus conference-based guideline delivering a clear proposal for diagnostic and treatment measures in each stage of rectal and colon cancer and the individual clinical situations. This ESMO guideline is recommended to be used as the basis for treatment and management decisions. © The Author 2012. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.
Authors & Co-Authors
Schmoll, Hans Joachim
Germany, Halle
Martin-luther-universität Halle-wittenberg
van Cutsem, Éric J.D.G.
Belgium, Leuven
Ku Leuven– University Hospital Leuven
Stein, A.
Germany, Hamburg
Universitätsklinikum Hamburg-eppendorf
Valentini, Vincenzo
Italy, Rome
Fondazione Policlinico Universitario Agostino Gemelli Irccs
Glimelius, Bengt L.G.
Sweden, Uppsala
Uppsala Universitet
Sweden, Stockholm
Karolinska Institutet
Haustermans, Karin M.G.
Belgium, Leuven
Ku Leuven– University Hospital Leuven
Nordlinger, Bernard M.
France, Boulogne-billancourt
Hopital Ambroise Pare, Boulogne-billancourt
France, Versailles
Université de Versailles Saint-quentin-en-yvelines
van de Velde, Cornelis J.H.
Netherlands, Leiden
Leids Universitair Medisch Centrum
Balmaña, Judith
Spain, Barcelona
Hospital Universitari Vall D'hebron
Regula, J.
Poland, Warsaw
Maria Sklodowska-curie National Research Institute of Oncology
Nagtegaal, I. D.
Netherlands, Nijmegen
Radboud University Medical Center
Beets-Tan, Regina G.H.
Netherlands, Maastricht
Maastricht Universitair Medisch Centrum+
Arnold, Dirk
Germany, Hamburg
Universitätsklinikum Hamburg-eppendorf
Ciardiello, Fortunato
Italy, Naples
Università Degli Studi Della Campania Luigi Vanvitelli
Hoff, Paulo Marcelo Gehm
Brazil, Bela Vista
Hospital Sirio-libanês
Brazil, Sao Paulo
Universidade de São Paulo
Kerr, David James
United Kingdom, Oxford
University of Oxford
Köhne, Claus Henning
Germany, Oldenburg
Klinikum Oldenburg
Labianca, R.
Italy, Bergamo
Ospedali Riuniti Di Bergamo
Price, Timothy J.
Australia, Woodville South
The Queen Elizabeth Hospital, North Western Adelaide Health Service
Scheithauer, W.
Austria, Vienna
Medizinische Universität Wien
Sobrero, A.
Italy, Genoa
Irccs San Martino Polyclinic Hospital
Tabernero, Josep Ma
Spain, Barcelona
Hospital Universitari Vall D'hebron
Aderka, Dan
Israel, Tel Hashomer Tel Aviv
Chaim Sheba Medical Center Israel
Barroso, S.
Portugal, Evora
Hospital do Espírito Santo
Bodoky, G.
Hungary, Budapest
St László Teaching Hospital
Douillard, Jean Yves
France, Saint-herblain
Institut de Cancérologie de L'ouest René-gauducheau
Elghazaly, Hesham A.
Egypt, Cairo
Ain Shams University
Gallardo, J.
Chile, Santiago
Clinica Alemana
Garin, A.
Russian Federation, Moscow
Blokhin National Medical Research Center of Oncology, Ministry of Health
Glynne-Jones, R.
United Kingdom, Northwood
Mount Vernon Hospital
Jordan, Karin
Germany, Halle
Martin-luther-universität Halle-wittenberg
Meshcheryakov, A.
Russian Federation, Moscow
Blokhin National Medical Research Center of Oncology, Ministry of Health
Papamichail, D.
Cyprus, Nicosia
Bank of Cyprus Group Oncology Centre
Pfeiffer, P.
Denmark, Odense
Odense Universitetshospital
Souglakos, I.
Greece, Heraklion
University of Crete Medical School
Turhal, S.
Turkey, Istanbul
Marmara Üniversitesi Tip Fakültesi
Cervantes, Andres
Spain, Valencia
Universitat de València
Statistics
Citations: 1,349
Authors: 37
Affiliations: 35
Identifiers
Doi:
10.1093/annonc/mds236
ISSN:
09237534
e-ISSN:
15698041
Research Areas
Cancer
Disability
Health System And Policy